Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK's consumer arm Haleon debuts with lacklustre valuation
GSK's consumer arm Haleon debuts with lacklustre valuation
GSK's consumer arm Haleon debuts with lacklustre valuation
Submitted by
admin
on July 18, 2022 - 7:11pm
Source:
Reuters
News Tags:
GSK
spinoffs
Haleon
consumer health
Headline:
GSK's consumer arm Haleon debuts with lacklustre valuation
snippet:
Haleon starts trading at 330 pence
Haleon valuation is at the lower end of expectations
Market value is below price Unilever was willing to pay
GSK stock down 0.7%
Do Not Allow Advertisers to Use My Personal information
